Case 2: Steroid-Refractory Acute Graft-Versus-Host Disease
Case 1: Personal Approach to Treatment for Acute GVHD
Case 1: Staging of Acute Graft-vs-Host Disease
Case 1: A Patient With Acute Graft-Vs-Host Disease
Case 1: GvHD Background
Graft-Versus-Host Disease
Experts in stem cell transplantation review the background of graft-versus-host disease and discuss 3 clinical cases and individualized treatment approaches.
Trials of Interest in Ovarian Cancer
Treating Ovarian Cancer With a PFI Less Than 6 Months
Case 3: Benefit of PARP Inhibitor Maintenance in Ovarian Cancer
Case 3: The OCEANS and GOG-0213 Trials for Ovarian Cancer
Case 3: Maintenance Therapy for Recurrent Ovarian Cancer
Case 3: Second-Line Therapy for Recurrent Ovarian Cancer
Case 2: Maintenance in BRCA1/2wt, HR-Proficient Ovarian Cancer
Case 2: Adding Bevacizumab to Chemotherapy in Ovarian Cancer
Case 1: Use of Niraparib in Ovarian Cancer
Case 1: Impact of Biomarkers on Maintenance Therapy
Case 1: Observation Versus Maintenance Therapy in Ovarian Cancer
CCA Important Developments and Practical Advice
Case 1: Use of Maintenance Therapy in Ovarian Cancer
Case 1: Diagnostic Tissue Testing in Ovarian Cancer
FGFR Versus Chemotherapy: DCR/DOR Efficacy
FGFR Inhibitor MOA and Adverse Events
Pivotal Trials in the Realm of Ovarian Cancer
An Overview of PARP Inhibitors in Ovarian Cancer
FGFR Inhibition in Advanced CCA
Adjuvant Chemotherapy + Bevacizumab for Ovarian Cancer
Metastatic Cholangiocarcinoma: Targeted Therapy and NGS
The Role of Targeted Therapies in Advanced Cholangiocarcinoma
A discussion on the development of targeted therapies for the management of advanced cholangiocarcinoma, with consideration of multiple ongoing trials with notable outcomes.
Ovarian Cancer
Experts in gynecological oncology review 3 clinical cases and best practices for various patients with newly diagnosed and recurrent ovarian cancer.
Future Directions in Managing KRAS-Mutant Advanced NSCLC